ICD-11 8A00: Parkinsonism Diagnostic Code Guide

Key Takeaways

ICD-11 code 8A00 classifies Parkinsonism under Diseases of the Nervous System

8A00 subcodes include 8A00.0 (Parkinson disease), 8A00.1 (Atypical parkinsonism), 8A00.2 (Secondary parkinsonism)

Etiology is captured through subcode selection (8A00.0 vs 8A00.2), not mandatory extension codes

WHO ICD-11 implementation changes workflow from ICD-10 G20-G21 codes

Short Introduction

ICD-11 8A00: Parkinsonism within the Diseases of the Nervous System chapter represents the World Health Organization’s updated classification system for movement disorders characterised by bradykinesia, rigidity, and tremor. This diagnostic code replaces ICD-10 codes G20 (Parkinson’s disease) and G21 (Secondary parkinsonism), introducing a pre-coordinated subcode structure that allows clinicians to specify etiology and clinical presentation. Neurologists, movement disorder specialists, and general practitioners managing patients with parkinsonian symptoms need accurate 8A00 code assignment to support treatment planning, research data capture, and international health statistics reporting.

The shift from ICD-10 to ICD-11 changes documentation workflows across neurology practices. Where ICD-10 G20 captured idiopathic Parkinson’s disease as a single entity, ICD-11 8A00 uses pre-coordinated subcodes: 8A00.0 for Parkinson disease, 8A00.1 for atypical parkinsonism, 8A00.2 for secondary parkinsonism, and 8A00.Z for unspecified cases. According to the World Health Organization ICD-11 browser, this structural change improves diagnostic precision but requires clinicians to capture additional clinical details during assessment. Practices using AI-powered clinical documentation can streamline this transition by prompting relevant diagnostic criteria during note generation.

What Is ICD-11 8A00: Parkinsonism?

ICD-11 code 8A00 classifies Parkinsonism as a clinical syndrome within the Diseases of the Nervous System chapter. The code captures movement disorders characterised by a combination of bradykinesia (slowness of movement) plus at least one additional feature: resting tremor, muscular rigidity, or postural instability. This definition aligns with Movement Disorder Society clinical diagnostic criteria but expands classification beyond idiopathic Parkinson’s disease to include secondary and atypical parkinsonian syndromes.

The 8A00 code hierarchy sits under parent code 8A (Extrapyramidal and movement disorders), which also includes dystonia, chorea, and tic disorders. Clinicians assign 8A00 when parkinsonian features are the dominant presenting syndrome. The code structure uses pre-coordinated subcodes to specify etiology. A 62-year-old patient presenting with bilateral bradykinesia, cogwheel rigidity, and resting tremor over 18 months would receive 8A00.0Z (Parkinson disease, unspecified) or 8A00.00 (Sporadic Parkinson disease) if no secondary cause is identified.

ICD-11 8A00 differs from its ICD-10 predecessor by providing explicit etiology subcodes. Where ICD-10 G20 captured idiopathic disease as a single code, 8A00 offers subcodes for Parkinson disease (8A00.0), atypical parkinsonism (8A00.1), secondary parkinsonism (8A00.2), and unspecified cases (8A00.Z). This change reflects advances in genetic testing, neuroimaging, and pharmaceutical monitoring that allow clinicians to differentiate primary from secondary Parkinsonism more reliably. Practices managing movement disorder patients should review their digital intake forms to capture medication histories and exposure data needed for accurate 8A00 subtype assignment.

ICD-11 8A00 Diagnostic Criteria and Clinical Guidelines

Assigning ICD-11 8A00 requires documented evidence of bradykinesia-observable slowing of voluntary movement initiation and execution. Clinicians assess bradykinesia through repetitive finger tapping, hand opening-closing, or pronation-supination tasks. The patient must demonstrate progressive decrement in amplitude or speed during these manoeuvres. Bradykinesia alone does not justify 8A00 assignment. The code requires at least one additional parkinsonian feature: resting tremor (4-6 Hz, suppressed by movement), rigidity (resistance to passive limb movement, often with cogwheel phenomenon), or postural instability (impaired righting reflexes on pull test).

Clinical examination findings must be reproducible across multiple assessments. A neurologist documenting 8A00 typically records Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores, noting asymmetry of symptom onset-a feature distinguishing idiopathic Parkinson’s disease from many secondary causes. The Movement Disorder Society diagnostic criteria specify that medication-naïve patients require two of three cardinal signs (bradykinesia, rigidity, tremor) plus asymmetric onset and progressive worsening over six months. Practices seeing high volumes of movement disorder patients benefit from structured assessment templates within their EMR software to ensure criterion documentation consistency.

Exclusion criteria prevent misclassification of alternative diagnoses as Parkinsonism. Clinicians must rule out drug-induced parkinsonism by reviewing dopamine antagonist exposure (antipsychotics, antiemetics, calcium channel blockers). Brain imaging excludes structural lesions or vascular pathology. Atypical features-early dementia, prominent hallucinations, rapid progression, or poor levodopa response-suggest alternative diagnoses like dementia with Lewy bodies or multiple system atrophy rather than code 8A00 Parkinsonism. When uncertainty exists, provisional 8A00 assignment with documented differential diagnosis allows for code revision as clinical course clarifies.

ICD-11 8A00 Subcode Structure

ICD-11 uses pre-coordinated subcodes under 8A00 to capture clinical nuance. The classification distinguishes idiopathic Parkinson disease (8A00.0) from secondary parkinsonism (8A00.1), which includes drug-induced, vascular, and toxic causes, and parkinsonism in diseases classified elsewhere (8A00.2). A 58-year-old with bilateral rest tremor and rigidity after two years of haloperidol treatment would receive 8A00.1 for secondary parkinsonism, flagging the iatrogenic cause. This specificity supports medication review and potential dose adjustment or alternative prescribing.

Hoehn-Yahr staging remains the standard Parkinson disease progression scale, and ICD-11 subcodes reflect disease stage through the classification structure. Stage 1 (unilateral symptoms) and stage 2 (bilateral without postural instability) both fall under 8A00.0 (Parkinson disease), while advanced disease with significant complications may involve additional codes for specific manifestations such as dementia in Parkinson disease (8A00.01) or dyskinesia. Neurologists document staging annually as part of longitudinal follow-up. According to NHS Digital clinical coding guidance, accurate subcode selection supports care pathway allocation and resource planning for advanced Parkinson services. Practices can configure their client record system to prompt severity reassessment at scheduled review intervals.

Clinical heterogeneity is captured through documentation rather than through post-coordination. Early-stage patients often show asymmetric symptom onset—document laterality in the clinical record to support surgical candidacy assessment for deep brain stimulation. Comorbidities such as dementia or depression are coded using their own ICD-11 codes alongside 8A00 subcodes: Lewy body disease uses 8A22, while depression and other conditions receive independent diagnostic codes. A 71-year-old with 12-year disease duration, bilateral symptoms, and cognitive decline receives 8A00.0 for Parkinson disease plus 8A22 for Lewy body disease if dementia criteria are met. This multi-code approach improves research dataset quality.

Documentation Requirements for ICD-11 8A00 Assignment

ICD-11 8A00 assignment requires specific clinical documentation elements captured during patient encounters. Clinicians must record observable motor findings-not patient-reported symptoms alone. A statement like “patient reports shaking hands” does not justify 8A00. The note must document examiner-observed resting tremor with frequency characteristics, suppression by voluntary movement, and reemergence after limb repositioning. Similarly, rigidity requires examiner notation of increased muscle tone during passive range of motion testing, ideally quantified using descriptors like “mild cogwheel rigidity in left upper limb.”

Medication history documentation prevents coding errors. Clinicians must list all dopamine antagonists, calcium channel blockers, or valproate exposure-medications known to induce secondary parkinsonism. The timeline matters: did symptoms begin within weeks of drug initiation, or did they predate medication exposure? A 45-year-old on long-term metoclopramide presenting with bilateral bradykinesia requires documented consideration of drug-induced versus coincidental idiopathic disease. Withdrawal trial outcomes-symptom resolution after stopping the offending agent-support secondary parkinsonism classification. Practices benefit from automated workflow alerts that flag dopamine antagonist prescriptions during Parkinsonism assessment encounters.

Disease progression tracking informs accurate staging and subcode selection. Annual documentation should note functional status changes: loss of independent ambulation, wheelchair dependence, or nursing home placement. Clinicians can use standardised scales-UPDRS motor score, Schwab and England Activities of Daily Living score, or Parkinson’s Disease Questionnaire (PDQ-39)-to quantify progression. These scores support severity documentation and justify escalation to advanced therapies. Structured templates within measurement tracking software ensure consistent scale administration across follow-up visits.

Transition from ICD-10 G20-G21 to ICD-11 8A00

The shift from ICD-10 to ICD-11 changes Parkinsonism coding fundamentally. ICD-10 G20 (Parkinson’s disease) captured idiopathic disease as a single code. G21 covered secondary parkinsonism with fourth-character subdivisions for drug-induced, vascular, or other specified causes. ICD-11 reorganises this into the 8A00 hierarchy with pre-coordinated subcodes. A patient previously coded G20 now receives 8A00.0 (Parkinson disease) or more specifically 8A00.00 (Sporadic Parkinson disease). A patient previously coded G21.0 (drug-induced) receives the appropriate 8A00.2 subcode for drug-induced secondary parkinsonism. G21.x codes map to various 8A00.2 subcodes based on the secondary cause.

This consolidation requires workflow adjustments for neurology practices. Where ICD-10 allowed clinicians to select G20 and defer etiology specification, ICD-11 provides subcodes for greater specificity, while 8A00.Z remains available for unspecified cases. Practices must modify their clinical templates to prompt etiology assessment during every Parkinsonism encounter. WHO guidance recommends mapping historical G20/G21 encounters to equivalent 8A00 codes during system transition. The WHO ICD-11 coding tool guide provides step-by-step mapping tables for common scenarios.

Billing implications vary by payer and jurisdiction. Countries adopting ICD-11 for morbidity reporting may not immediately align reimbursement systems with the new code structure. Clinicians should verify whether their revenue cycle management requires ICD-10 backward-mapping for claims submission during transition periods. Some jurisdictions maintain dual coding-ICD-11 for clinical records, ICD-10 for billing-until payers update their systems. Practices using claims management software should confirm their vendor supports ICD-11 forward-coding and automatic backward-mapping when required.

Common ICD-11 8A00 Coding Errors and How to Avoid Them

A common 8A00 coding error is using the base 8A00 or 8A00.Z when more specific subcodes are clinically supported. While 8A00.Z (unspecified) is a valid code, using it when the etiology is known reduces data quality. Clinicians should select the most specific subcode available: 8A00.00 for sporadic Parkinson disease, 8A00.01 for familial cases, or the appropriate 8A00.2 subcode for secondary parkinsonism. EHR systems should prompt clinicians to select a specific subcode rather than defaulting to unspecified.

Misclassification of atypical parkinsonism as 8A00 represents another common error. Some atypical conditions sit within 8A00 while others are classified elsewhere. Progressive supranuclear palsy is 8A00.10, within the 8A00.1 (atypical parkinsonism) hierarchy. However, multiple system atrophy with parkinsonism is 8D87.01, and Lewy body disease is 8A22—both outside 8A00. These syndromes present with parkinsonian features but include red flags: early falls, vertical gaze palsy, alien limb phenomenon, or dysautonomia. A 67-year-old with bradykinesia plus severe orthostatic hypotension and urinary retention likely has multiple system atrophy (8D87.01), not 8A00. Clinicians should document differential diagnosis considerations and flag atypical features that warrant alternative code selection.

Failing to update 8A00 extensions as disease progresses creates longitudinal coding inconsistency. A patient coded 8A00.00 (sporadic Parkinson disease) at diagnosis five years ago who now shows bilateral involvement with postural instability should have their clinical staging documentation updated at each review. The ICD-11 subcode (8A00.00) remains the same, but Hoehn-Yahr staging in the clinical record should reflect current disease severity. Practices can configure their appointment scheduling system to automatically prompt staging reassessment at annual neurology follow-ups, ensuring coders have current clinical data for accurate assignment.

Streamline ICD-11 Coding Workflows

Pabau's clinical documentation system prompts appropriate ICD-11 subcodes during note generation, reducing coding errors and supporting accurate Parkinsonism classification. Built-in validation ensures specific subcode selection.

Book a demo

Differential Diagnosis and Related ICD-11 Codes

Distinguishing ICD-11 8A00 Parkinsonism from phenotypically similar conditions requires systematic assessment. Essential tremor (8A04) presents with action tremor rather than rest tremor and lacks bradykinesia. A 72-year-old with bilateral hand tremor during writing and eating but normal finger tapping speed receives 8A04, not 8A00. Drug-induced movement disorders are coded under 8A4Y or the specific movement disorder subtype. Acute dystonic reactions and tardive dyskinesia have their own ICD-11 codes—distinct from chronic drug-induced parkinsonism coded under 8A00.2. The timing and phenomenology differ: acute dystonia occurs within hours of drug exposure, while drug-induced parkinsonism develops over weeks to months.

Atypical parkinsonian syndromes occupy separate ICD-11 categories despite overlapping motor features. Progressive supranuclear palsy (8A00.10) sits within the 8A00.1 atypical parkinsonism hierarchy. Multiple system atrophy with parkinsonism (8D87.01) is classified outside 8A00 under degenerative diseases of the nervous system. Corticobasal degeneration is also classified separately. Lewy body disease (8A22) encompasses both the neurological condition and its dementia manifestation. Clinicians should distinguish 8A22 from 8A00.0 based on the clinical presentation—when cognitive decline with visual hallucinations and fluctuating attention predominates over motor symptoms, 8A22 is more appropriate. Clinicians document clinical features distinguishing 8A00 from these alternatives to support code specificity.

Vascular parkinsonism (coded under 8A00.2) requires neuroimaging evidence of cerebrovascular disease plus lower-body-predominant parkinsonism-gait disturbance and postural instability more prominent than upper limb symptoms. Brain MRI shows white matter hyperintensities or lacunar infarcts in the basal ganglia. This subtype responds poorly to levodopa compared to idiopathic Parkinson’s disease. A 76-year-old with small-vessel ischemic changes on MRI and predominantly lower-limb rigidity receives the appropriate 8A00.2 subcode for secondary parkinsonism, not 8A00.0. Differential diagnosis documentation ensures appropriate code selection and guides treatment expectations.

ICD-11 8A00 in Research and Health Statistics

ICD-11 8A00 coding improves global Parkinson’s disease epidemiology by standardising etiology capture. ICD-10 G20 prevalence studies could not differentiate idiopathic from secondary cases without chart review. ICD-11 subcodes embed this distinction in the diagnostic code itself. Researchers querying health databases can now isolate drug-induced parkinsonism (8A00.2 subcodes) from genetic forms (8A00.01) or sporadic Parkinson disease (8A00.00) using structured data alone. This granularity enables more precise incidence calculations, risk factor identification, and treatment outcome comparisons across Parkinsonism subtypes.

Clinical trials benefit from ICD-11’s structured classification. Recruitment for neuroprotective therapy trials targeting early-stage idiopathic Parkinson disease can screen electronic health records for 8A00.0 (Parkinson disease) combined with Hoehn-Yahr stage documentation. This precision reduces manual chart review burden and accelerates trial enrolment. Pharmaceutical companies designing real-world evidence studies use subcodes to stratify outcomes by disease type or comorbidity burden. A post-marketing surveillance study assessing dyskinesia incidence can query for dyskinesia codes alongside 8A00.0 diagnoses in coded data.

National health systems leverage ICD-11 8A00 data for service planning. Severity extensions reveal the proportion of Parkinson’s patients at advanced stages requiring specialised care-deep brain stimulation candidacy, palliative services, or nursing home placement. Jurisdictions with high prevalence of advanced-stage Parkinson disease (8A00.0) face greater demand for movement disorder specialists and allied health services. Health ministries use these data to allocate neurology residency training positions and specialty clinic funding. Accurate ICD-11 coding at the practice level aggregates into population-level insights that shape health policy decisions.

ICD-11 8A00 Implementation in Clinical Practice

Implementing ICD-11 8A00 coding requires electronic health record configuration changes. Practices must update code libraries, replacing ICD-10 G20/G21 with 8A00 and its subcodes. Dropdown menus or structured pick-lists prompt clinicians to select the appropriate subcode during note documentation. Pre-built templates can auto-populate common selections—8A00.0 for Parkinson disease, 8A00.1 for secondary parkinsonism, 8A00.00 for Parkinson disease without dementia, 8A00.01 for Parkinson disease with dementia. Configuring these workflows before WHO mandates ICD-11 use allows practices to identify and resolve system limitations during low-stakes transition periods.

Staff training focuses on subcode logic and selection criteria. Clinicians need reference guides mapping clinical scenarios to appropriate subcodes. A laminated card listing the key subcodes (8A00.0 = Parkinson disease, 8A00.1 = secondary parkinsonism, 8A00.2 = parkinsonism in diseases classified elsewhere, 8A00.Z = unspecified) supports point-of-care coding decisions. Regular case-based learning sessions review coding scenarios: “58-year-old on metoclopramide with bilateral rigidity—which subcode?” Coders who previously relied on G20 as a default diagnosis must now think critically about the underlying cause and explicitly document their reasoning. Practices should budget training time during the months preceding mandatory ICD-11 adoption.

Interoperability between systems requires ICD-11 8A00 support across the care ecosystem. If neurology practices adopt ICD-11 but referring GP clinics remain on ICD-10, referral letters need translation layers. Health information exchanges should implement bidirectional mapping: 8A00.00 converts to G20 for ICD-10-only systems, while incoming G20 codes prompt clinicians to select the appropriate 8A00 subcode when documenting within ICD-11 environments. Practices considering multi-location management software should verify that all sites operate on the same ICD version to prevent coding fragmentation across locations.

Expert Picks

Need structured clinical assessment tools? Psychiatric Evaluation Template demonstrates comprehensive mental status documentation that can be adapted for movement disorder assessment.

Looking for patient education resources? Mental Health EMR features show how digital platforms support condition-specific patient portals and educational content delivery.

Want to improve coding accuracy? Echo AI clinical documentation prompts diagnostic criteria during note generation, reducing omissions that lead to incomplete code assignment.

Conclusion

ICD-11 8A00 Parkinsonism coding represents a significant advance in movement disorder classification. The pre-coordinated subcode structure (8A00.0 Parkinson disease, 8A00.1 atypical, 8A00.2 secondary, 8A00.Z unspecified) captures etiology distinctions that ICD-10 G20/G21 codes could not express. Neurology practices transitioning to ICD-11 must update documentation workflows, train staff on subcode selection, and configure EHR systems to support the 8A00 hierarchy. Accurate 8A00 coding improves research data quality, enables precise epidemiological tracking, and supports individualised treatment planning based on Parkinsonism subtype.

Clinicians should focus implementation efforts on three areas: embedding subcode selection prompts within clinical templates, conducting regular coding audits to identify documentation gaps, and maintaining updated reference materials for point-of-care decision support. As countries adopt ICD-11 for morbidity reporting and health statistics, practices that proactively implement 8A00 subcode workflows will experience smoother transitions than those deferring preparation until regulatory deadlines. The investment in structured Parkinsonism documentation pays dividends through improved clinical precision, streamlined research participation, and enhanced longitudinal disease tracking for individual patients.

Frequently Asked Questions